openPR Logo
Press release

Peptide Synthesis Market worth $1,080.42 million by 2030, growing at a CAGR of 7.84% - Exclusive Report by 360iResearch

02-26-2024 11:36 AM CET | Health & Medicine

Press release from: 360iResearch

Peptide Synthesis Market | 360iResearch

Peptide Synthesis Market | 360iResearch

The "Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Peptide Synthesis Market to grow from USD 636.71 million in 2023 to USD 1,080.42 million by 2030, at a CAGR of 7.84%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/peptide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Peptide synthesis is a complex and advanced chemical process that entails the formation of peptides, which are short chains of amino acids linked by peptide bonds. These peptides play several critical roles in various biological systems, including signaling, regulation of cellular processes, and maintaining structural components. The technique involves adding amino acids to a growing polypeptide chain stepwise while protecting specific functional groups and ensuring high fidelity throughout the process. There is a higher demand for peptide therapeutics due to their increased applications, and pharmaceutical research activities and funding are on the rise across various economies. Moreover, the cosmetics industry is experiencing a growing need for bioactive peptides, contributing to increased peptide synthesis adoption. The lack of standardized rules and regulations for peptide design and difficulties in peptide production hinders its usage. However, the introduction of advanced peptide synthesizers and technologies developed for peptide design and the potential utilization of peptides in nutraceuticals and food preservation is expected to boost their synthesis in the future.

Peptide synthesis is a crucial technique in the field of biochemistry and pharmaceutical research across the Americas. In North America, the United States holds a dominant position in peptide synthesis usage due to its well-established biopharmaceutical industry, extensive research infrastructure, and considerable investment in life sciences. In South America, countries such as Brazil and Mexico are witnessing increased adoption of peptide synthesis technologies due to expanding biotechnology sectors and governmental support towards research initiatives. The Asia-Pacific peptide synthesis market's robust growth can be attributed to increased R&D investments by governments and private entities, surging demand for novel therapeutic solutions, expanding pharmaceutical & biotechnology industries' footprint within the region, and a thriving CRO landscape. The peptide synthesis market in the EMEA region is experiencing significant growth, driven by technological advancements in synthesizers, increased funding for research and development activities, and a growing demand for synthetic peptides in pharmaceuticals, biotechnology, and other industries. The market has witnessed an influx of new players and collaborations among existing participants to develop innovative technologies for peptide synthesis.

Market Segmentation & Coverage:

This research report categorizes the Peptide Synthesis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Equipment, Reagents, and Services. The Equipment is further studied across Chromatography Equipment, Lyophilizers, and Peptide Synthesizers. The Reagents is further studied across Amino Acids, Base Resins, Peptide Coupling Reagents, and Peptide Labeling Reagents. The Services is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, and Solution-Phase Synthesis. The Hybrid & Recombinant Technology is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic & Research Institutes, Contract Development & Manufacturing Organization/Contract Research Organization, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.96% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/peptide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Peptide Synthesis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Peptide Synthesis Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Peptide Synthesis Market, by Product
7. Peptide Synthesis Market, by Technology
8. Peptide Synthesis Market, by End User
9. Americas Peptide Synthesis Market
10. Asia-Pacific Peptide Synthesis Market
11. Europe, Middle East & Africa Peptide Synthesis Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Peptide Synthesis Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Peptide Synthesis Market?
3. What is the competitive strategic window for opportunities in the Peptide Synthesis Market?
4. What are the technology trends and regulatory frameworks in the Peptide Synthesis Market?
5. What is the market share of the leading vendors in the Peptide Synthesis Market?
6. What modes and strategic moves are considered suitable for entering the Peptide Synthesis Market?

Read More @ https://www.360iresearch.com/library/intelligence/peptide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Synthesis Market worth $1,080.42 million by 2030, growing at a CAGR of 7.84% - Exclusive Report by 360iResearch here

News-ID: 3399122 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Peptide

Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). [https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established